Wearable Devices Ltd. Sells 440,000 Shares in Direct Offering
Ticker: WLDSW · Form: 6-K · Filed: Sep 11, 2025 · CIK: 1887673
| Field | Detail |
|---|---|
| Company | Wearable Devices Ltd. (WLDSW) |
| Form Type | 6-K |
| Filed Date | Sep 11, 2025 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 7 min |
| Key Dollar Amounts | $4.00, $3.9999, $0.0001, $65,000, $4 Million |
| Sentiment | neutral |
Sentiment: neutral
Topics: offering, shares, foreign-private-issuer
TL;DR
WDL is selling 440K shares to an investor on 9/11/25.
AI Summary
On September 11, 2025, Wearable Devices Ltd. entered into a Securities Purchase Agreement with an institutional investor to sell 440,000 ordinary shares in a registered direct offering. The filing is a Report of Foreign Private Issuer for the month of September 2025.
Why It Matters
This offering provides capital for Wearable Devices Ltd. through the sale of its ordinary shares to an institutional investor.
Risk Assessment
Risk Level: medium — The company is issuing new shares, which can dilute existing shareholders and may indicate a need for capital.
Key Numbers
- 440,000 — Ordinary Shares (Number of shares sold in the registered direct offering.)
Key Players & Entities
- Wearable Devices Ltd. (company) — Registrant
- September 11, 2025 (date) — Date of Purchase Agreement
- 440,000 (dollar_amount) — Number of ordinary shares to be sold
FAQ
What is the total number of ordinary shares Wearable Devices Ltd. agreed to sell?
Wearable Devices Ltd. agreed to sell 440,000 ordinary shares.
When was the Securities Purchase Agreement entered into?
The Securities Purchase Agreement was entered into on September 11, 2025.
Who is the counterparty in the Securities Purchase Agreement?
The counterparty is a single institutional investor, referred to as the Purchaser.
What type of offering is this transaction?
This transaction is a registered direct offering by the Company directly to the Purchaser.
What form is this filing?
This filing is a Form 6-K, Report of Foreign Private Issuer.
Filing Stats: 1,641 words · 7 min read · ~5 pages · Grade level 13.1 · Accepted 2025-09-11 16:31:03
Key Financial Figures
- $4.00 — Shares”), at an offering price of $4.00 per share; and (ii) pre-funded warrants
- $3.9999 — arrants”) at an offering price of $3.9999 per Pre-Funded Warrant. The Pre-Funded
- $0.0001 — Ordinary Share at an exercise price of $0.0001 per share. The Pre-Funded Warrants are
- $65,000 — the offering in an amount not to exceed $65,000. The foregoing summaries of the Placem
- $4 Million — o;Wearable Devices Announces Pricing of $4 Million Registered Direct Offering and Concurre
Filing Documents
- ea0256950-6k_wearable.htm (6-K) — 26KB
- ea025695001ex4-1_wearable.htm (EX-4.1) — 92KB
- ea025695001ex4-2_wearable.htm (EX-4.2) — 84KB
- ea025695001ex5-1_wearable.htm (EX-5.1) — 11KB
- ea025695001ex5-2_wearable.htm (EX-5.2) — 12KB
- ea025695001ex10-1_wearable.htm (EX-10.1) — 48KB
- ea025695001ex10-2_wearable.htm (EX-10.2) — 237KB
- ea025695001ex99-1_wearable.htm (EX-99.1) — 13KB
- ex5-1_001.jpg (GRAPHIC) — 3KB
- ex5-2_001.jpg (GRAPHIC) — 8KB
- ex5-2_002.jpg (GRAPHIC) — 8KB
- 0001213900-25-086848.txt ( ) — 549KB
Forward-Looking Statements
Forward-Looking Statements : This Report contains forward-looking other federal securities laws. For example, the Company is using forward-looking statements when it discusses the closing of the Offering. All statements other than statements of historical facts included in this Report are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include the risks and uncertainties described in the Company’s annual report on Form 20-F for the year ended December 31, 2024, filed with the Commission on March 20, 2025, and the Company’s other filings with the Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. 2 EXHIBIT INDEX Exhibit No. Description 4.1 Form of Ordinary Warrant. 4.2 Form of Pre-Funded Warrant. 5.1 Opinion of Sullivan & Wor
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Wearable Devices Ltd. Date: September 11, 2025 By: /s/ Asher Dahan Asher Dahan Chief Executive Officer 4